Analysis of signaling events by dynamic phosphoflow cytometry

Science Signaling

Volumn 2, Issue 86, 2009, Pages

  Firaguay, Guylène ^a,b,c   Nunès, Jacques A ^a,b,c  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOPROTEIN; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; ANTIBODY; DRUG; PERVANADATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN KINASE; VANADIC ACID;

CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; ARTICLE; CALIBRATION; CELL STRAIN U937; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION; GENETICS; KINETICS; METABOLISM; METHODOLOGY; MUTATION; PHOSPHORYLATION; PHYSIOLOGY;

ANTIBODIES; CALIBRATION; CELL SURVIVAL; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; KINETICS; MUTATION; PHARMACEUTICAL PREPARATIONS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASES; PROTEINS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; U937 CELLS; VANADATES;

EID: 73949103809     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.286pl3     Document Type: Review

References (26)

1. F. Delom, E. Chevet, Phosphoprotein analysis: From proteins to proteomes. Proteome Sci. 4, 15 (2006).
2. M. P. Myers, I. Pass, I. H. Batty, J. Van der Kaay, J. P. Stolarov, B. A. Hemmings, M. H. Wigler, C. P. Downes, N. K. Tonks, The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. U.S.A. 95, 13513-13518 (1998).
3. M. Cully, H. You, A. J. Levine, T. W. Mak, Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184-192 (2006).
4. R. W. Freeburn, K. L. Wright, S. J. Burgess, E. Astoul, D. A. Cantrell, S. G. Ward, Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J. Immunol. 169, 5441-5450 (2002).
5. M. Pallis, C. Seedhouse, M. Grundy, N. Russell, Flow cytometric measurement of phosphorylated STAT5 in AML: Lack of specific association with FLT3 internal tandem duplications. Leuk. Res. 27, 803-805 (2003).
6. Y. P. Lim, Mining the tumor phosphoproteome for cancer markers. Clin. Cancer Res. 11, 3163-3169 (2005).
7. G. Huyer, S. Liu, J. Kelly, J. Moffat, P. Payette, B. Kennedy, G. Tsaprailis, M. J. Gresser, C. Ramachandran, Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J. Biol. Chem. 272, 843-851 (1997). (Pubitemid 27034572)
8. M. P.Wymann, G. Bulgarelli-Leva, M. J. Zvelebil, L. Pirola, B. Vanhaesebroeck, M. D.Waterfield, G. Panayotou, Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol. Cell. Biol. 16, 1722-1733 (1996).
9. T. Harder, M. Kuhn, Immunoisolation of TCR signaling complexes from Jurkat T leukemic cells. Sci. STKE 2001, pl1 (2001).
10. S.Yoon, R. Seger, The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors 24, 21-44 (2006).
11. P. O. Krutzik, J. M. Irish, G. P. Nolan, O. D. Perez, Analysis of protein phosphorylation and cellular signaling events by flow cytometry: Techniques and clinical applications. Clin. Immunol. 110, 206-221 (2004).
12. A. Pandey, J. S. Andersen, M. Mann, Use of mass spectrometry to study signaling pathways. Sci. STKE 2000, pl1 (2000).
13. H. Steen, A. Pandey, J. S. Andersen, M. Mann, Analysis of tyrosine phosphorylation sites in signaling molecules by a phosphotyrosine-specific immonium ion scanning method. Sci. STKE 2002, pl16 (2002).
14. M. O. Collins, L.Yu, H. Husi, W. P. Blackstock, J. S. Choudhary, S. G. Grant, Robust enrichment of phosphorylated species in complex mixtures by sequential protein and peptide metal-affinity chromatography and analysis by tandem mass spectrometry. Sci. STKE 2005, pl6 (2005).
15. P. R. Cutillas, A. Khwaja, M. Graupera, W. Pearce, S. Gharbi, M. Waterfield, B. Vanhaesebroeck, Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 103, 8959-8964 (2006).
16. S. A. Johnson, T. Hunter, Kinomics: Methods for deciphering the kinome. Nat. Methods 2, 17-25 (2005).
17. N. R. Gough, Detecting signaling in single cells. Sci. Signal. 1, ec406 (2008).
18. R. Cheong, C. J.Wang, A. Levchenko, Using a microfluidic device for high-content analysis of cell signaling. Sci. Signal. 2, pl2 (2009).
19. R. Varro, R. Chen, H. Sepulveda, J. Apgar, Bead-based multianalyte flow immunoassays: The cytometric bead array system. Methods Mol. Biol. 378, 125-152 (2007).
20. P. O. Krutzik, J. M. Crane, M. R. Clutter, G. P. Nolan, High-content single-cell drug screening with phosphospecific flow cytometry. Nat. Chem. Biol. 4, 132-142 (2008).
21. J. M. Irish, R. Hovland, P. O. Krutzik, O. D. Perez, O. Bruserud, B. T. Gjertsen, G. P. Nolan, Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118, 217-228 (2004).
22. P. L. Dahia, R. C. Aguiar, J. Alberta, J. B. Kum, S. Caron, H. Sill, D. J. Marsh, J. Ritz, A. Freedman, C. Stiles, C. Eng, PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum. Mol. Genet. 8, 185-193 (1999).
23. R. C. Hui, A. R. Gomes, D. Constantinidou, J. R. Costa, C. T. Karadedou, S. Fernandez de Mattos, M. P.Wymann, J. J. Brosens, A. Schulze, E.W. Lam, The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression. Mol. Cell. Biol. 28, 5886-5898 (2008).
24. + CML stem cells by CrkL phosphorylation status using flow cytometry. Leukemia 20, 1035-1039 (2006).
25. M. M. Hammer, N. Kotecha, J. M. Irish, G. P. Nolan, P. O. Krutzik, WebFlow: A software package for high-throughput analysis of flow cytometry data. Assay Drug Dev. Technol. 7, 44-55 (2009).
26. This work was supported by grants from Institut National de la Santé et de la Recherche Médicale and the Institut National du Cancer (#PL-06026).